[go: up one dir, main page]

AR053979A1 - Hidrato de n-metil-n-(3-[3-[2-tienilcarbonil]-pirazol-[1,5-a-pirimidin-7-il]fenil)acetamida y procesos de obtencion - Google Patents

Hidrato de n-metil-n-(3-[3-[2-tienilcarbonil]-pirazol-[1,5-a-pirimidin-7-il]fenil)acetamida y procesos de obtencion

Info

Publication number
AR053979A1
AR053979A1 ARP050104341A ARP050104341A AR053979A1 AR 053979 A1 AR053979 A1 AR 053979A1 AR P050104341 A ARP050104341 A AR P050104341A AR P050104341 A ARP050104341 A AR P050104341A AR 053979 A1 AR053979 A1 AR 053979A1
Authority
AR
Argentina
Prior art keywords
pyrimidin
acetamide
phenyl
methyl
hydrate
Prior art date
Application number
ARP050104341A
Other languages
English (en)
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of AR053979A1 publication Critical patent/AR053979A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procesos de obtencion de dicho compuesto. Reivindicacion 1: Un hidrato caracterizado porque es de N-metil-N-(3-{3-[2-tienilcarbonil]-pirazol-[1,5-alfa]-pirimidin-7-il}fenil)-acetamida.
ARP050104341A 2004-10-18 2005-10-17 Hidrato de n-metil-n-(3-[3-[2-tienilcarbonil]-pirazol-[1,5-a-pirimidin-7-il]fenil)acetamida y procesos de obtencion AR053979A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62001404P 2004-10-18 2004-10-18

Publications (1)

Publication Number Publication Date
AR053979A1 true AR053979A1 (es) 2007-05-30

Family

ID=35708797

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104341A AR053979A1 (es) 2004-10-18 2005-10-17 Hidrato de n-metil-n-(3-[3-[2-tienilcarbonil]-pirazol-[1,5-a-pirimidin-7-il]fenil)acetamida y procesos de obtencion

Country Status (6)

Country Link
US (2) US7304069B2 (es)
EP (1) EP1844047A1 (es)
JP (1) JP5156381B2 (es)
AR (1) AR053979A1 (es)
TW (1) TW200630368A (es)
WO (1) WO2006044903A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918290A1 (en) 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
US6472528B1 (en) * 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
MXPA05002251A (es) * 2002-08-26 2005-06-08 Neurocrine Biosciences Inc Polimorfo novedoso del n- metil -n- (3- {3-[2- tienilcarbonil] -pirazol -[1, 5-(alfa)] -pirimidina- 7-yl} fenil) acetamida y composiciones y metodos relacionados.
EP1742624B1 (en) * 2004-02-18 2010-01-06 Sepracor, Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality

Also Published As

Publication number Publication date
US20060116387A1 (en) 2006-06-01
WO2006044903A1 (en) 2006-04-27
US20080132700A1 (en) 2008-06-05
EP1844047A1 (en) 2007-10-17
JP5156381B2 (ja) 2013-03-06
JP2008516987A (ja) 2008-05-22
TW200630368A (en) 2006-09-01
US7304069B2 (en) 2007-12-04

Similar Documents

Publication Publication Date Title
IS7769A (is) Nýr fjölgervingur N-metýl-N-(3-{3-[2-þíenýlkarbónýl]-pýrasól-[1,5-alfa]-pýrimídin-7-ýl}fenýl)asetamíðs og efnablöndur og aðferðir tengdar honum
IS7534A (is) Pýrazóló-pýrimídín anilín efnasambönd, gagnleg sem kínasatálmar
DE602004006659D1 (de) Vorrichtung zur Regelung von Kurbelwellengas
EP1762234A4 (en) AMPK AKTIVATOR
IL185002A0 (en) Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substituted by amino and phenyl groups
DE602005003619D1 (de) Teilchenförmiges Mattierungsmittel
DE60223846D1 (de) Vorrichtung für einen verbrennungsmotor
DE602006007463D1 (de) Motorluftverwaltungssystem
EP1795728A4 (en) DEVICE FOR ESTIMATING AIR AMOUNT FOR INTERNAL COMBUSTION ENGINE
EP1746275A4 (en) ANOMALY DETECTION DEVICE FOR INTERNAL COMBUSTION ENGINE
DE60316549D1 (de) Vorrichtung zur Bestimmung des Kraftstoffverbrauches eines Fahrzeuges
GB2438322B (en) Idle state management
AR053979A1 (es) Hidrato de n-metil-n-(3-[3-[2-tienilcarbonil]-pirazol-[1,5-a-pirimidin-7-il]fenil)acetamida y procesos de obtencion
DE60320801D1 (de) Vorrichtung zur harnstoffherstellung
DE60308966D1 (de) Vorrichtung für die Zufuhr von Atemgas
EA200700681A1 (ru) Активирующие агенты для металлоценовых компонентов на основе гафния
DE60313683D1 (de) Gas-Flüssigkeitsabscheider für Stampferbrennkraftmaschine
DE10393418D2 (de) Hubkolbenmaschine
ATE470205T1 (de) Gehäuse
ZA200706391B (en) Sphingosine 1-phosphate agonists comprising cycloalkanes and 5-membered heterocycles substituted by amino and phenyl groups
DE602006009510D1 (de) Verfahren zum herauffahren eines endgeräts, speicher und endgerät dafür
DE602005005883D1 (de) Integrierte Versorgungseinheit für Brennkraftmaschinen
ITTO20050652A1 (it) Filtro dell'aria per motocicli.
DE50301605D1 (de) Druckknopfsicherung für Schnellfeuergewehre
RU2005125623A (ru) Способ получения 4:5-бензо-1,3,6,8-тетраазатрицикло-[4.3.1.1 3,8]-4-ундецена (бензоуротропина)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal